Literature DB >> 29595503

Tuberculosis research and development: seeding the future.

Christian Lienhardt1, Alimuddin Zumla2, Nebiat Gebreselassie3, Mike Frick4, Glenda Gray5, Tereza Kasaeva3, Mario Raviglione6.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29595503     DOI： 10.1016/S2213-2600(18)30050-X

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  3 in total

1.  Exploring local realities: Perceptions and experiences of healthcare workers on the management and control of drug-resistant tuberculosis in Addis Ababa, Ethiopia.

Authors:  Kirubel Manyazewal Mussie; Solomon Abebe Yimer; Tsegahun Manyazewal; Christoph Gradmann
Journal:  PLoS One       Date:  2019-11-13       Impact factor: 3.240

2.  Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different.

Authors:  Allison LaHood; Rifat Rahman; Lindsay McKenna; Mike Frick; Carole D Mitnick
Journal:  PLoS One       Date:  2022-07-25       Impact factor: 3.752

3.  New perspectives on an ancient pathogen: thoughts for World Tuberculosis Day 2022.

Authors:  Dany J V Beste
Journal:  Microbiology (Reading)       Date:  2022-03       Impact factor: 2.956
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.